CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 28, 2025	Dec. 29, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net Income (Loss)	$ 601,704	$ 584,170	$ 519,118
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	88,827	87,732	80,640
Refranchising (gain) loss	(4,028)	158	149
Loss on sale/disposal of assets	1,855	1,527	1,299
Amortization of debt issuance costs	5,748	5,298	5,535
Provision (benefit) for deferred income taxes	1,288	(9,117)	(19,509)
Non-cash equity-based compensation expense	44,640	43,255	37,514
Excess tax benefits from equity-based compensation	(3,158)	(22,241)	(3,397)
(Benefit) provision for losses on accounts and notes receivable	(109)	191	1,472
Unrealized and realized losses (gains) on investments, net	2,544	(22,064)	(17,713)
Changes in operating assets and liabilities:
Accounts receivable	(6,149)	(27,353)	(26,515)
Inventories, prepaid expenses and other	(6,700)	6,651	160
Accounts payable and accrued liabilities	53,637	(10,218)	69,373
Insurance reserves	536	(5,557)	(5,163)
Operating lease assets and liabilities	691	(558)	632
Advertising fund assets and liabilities, restricted	10,736	(6,977)	(52,731)
Net cash provided by operating activities	792,062	624,897	590,864
Cash flows from investing activities:
Capital expenditures	(120,558)	(112,885)	(105,396)
Sale of investments	44,085	82,918	0
Proceeds from sale of assets	8,558	74	161
Other	(2,275)	(1,336)	(1,682)
Net cash used in investing activities	(70,190)	(31,229)	(106,917)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	1,000,000	0	14,898
Repayments of long-term debt and finance lease obligations	(1,149,528)	(17,647)	(55,705)
Proceeds from exercise of stock options	18,792	36,024	8,656
Purchases of common stock	(357,697)	(329,557)	(269,025)
Tax payments for restricted stock upon vesting	(11,360)	(11,098)	(5,410)
Payments of common stock dividends and equivalents	(236,861)	(209,945)	(169,772)
Cash paid for financing costs	(15,439)	0	0
Net cash used in financing activities	(752,093)	(532,223)	(476,358)
Effect of exchange rate changes on cash	1,782	(2,154)	340
Change in cash and cash equivalents, restricted cash and cash equivalents	(28,439)	59,291	7,929
Cash and cash equivalents, beginning of period	186,126	114,098	60,356
Restricted cash and cash equivalents, beginning of period	195,370	200,870	191,289
Cash and cash equivalents included in advertising fund assets, restricted, beginning of period	80,928	88,165	143,559
Cash and cash equivalents, restricted cash and cash equivalents and cash and cash equivalents included in advertising fund assets, restricted, beginning of period	462,424	403,133	395,204
Cash and cash equivalents, end of period	125,675	186,126	114,098
Restricted cash and cash equivalents, end of period	216,110	195,370	200,870
Cash and cash equivalents included in advertising fund assets, restricted, end of period	92,200	80,928	88,165
Cash and cash equivalents, restricted cash and cash equivalents and cash and cash equivalents included in advertising fund assets, restricted, end of period	$ 433,985	$ 462,424	$ 403,133